Ad
Friday, 27 October 2017
Merck profit beat clouded by NotPetya attack, shares dip
(Reuters) - Merck & Co reported profit ahead of Street estimates on strong sales of its cancer drug Keytruda but total revenue fell in the quarter from disruptions due to the NotPetya cyber attack and loss of market share for many of its older drugs.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment